Recital 4, Regulation (EU) 2023/2384

In forcesince 29 Sep 2023

On 29 April 2022, the Agency submitted an opinion [ECHA opinion on an administrative change of the Union authorisation of QUAT-CHEM’s iodine based products of 13 August 2021, Opinion No UTR-C-1527940-77-00/F, https://echa.europa.eu/opinions-on-union-authorisation] to the Commission on the proposed change, in accordance with Article 11(3) of Implementing Regulation (EU) No 354/2013. The opinion concludes that the amendment to the existing authorisation sought by the authorisation holder falls under Article 50(3), point (a), of Regulation (EU) No 528/2012, that the parties have agreed to the transfer of the authorisation, that the prospective new authorisation holder is established in the Union, and that after the implementation of the changes, the conditions of Article 19 of that Regulation are still met. On the same date, the Agency transmitted to the Commission the revised summary of the biocidal product characteristics in all the official languages of the Union in accordance with Article 11(6) of Implementing Regulation (EU) No 354/2013.